Teriparatide -: rhPTH(1-34) -: LY-333334 -: Forteo® -: Treatment of osteoporosis -: Parathyroid hormone

被引：0
|
作者：
不详
机构：
来源：
DRUGS OF THE FUTURE | 2001年 / 26卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：824 / 827
页数：4
相关论文
共 50 条
  • [21] Treatment of Osteoporosis with Parathyroid Hormone and Teriparatide
    Johannes Pleiner-Duxneuner
    Elisabeth Zwettler
    Eleftherios Paschalis
    Paul Roschger
    Valerie Nell-Duxneuner
    Klaus Klaushofer
    [J]. Calcified Tissue International, 2009, 85 (5) : 463 - 463
  • [22] The managing your osteoporosis (MYO) program for patients starting therapy with teriparatide injection [rhPTH (1-34)]
    Drews, T.
    Valentine, V.
    Wong, M.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (06): : 1085 - 1085
  • [23] Treatment of Osteoporosis with Parathyroid Hormone and Teriparatide
    Pleiner-Duxneuner, Johannes
    Zwettler, Elisabeth
    Paschalis, Eleftherios
    Roschger, Paul
    Nell-Duxneuner, Valerie
    Klaushofer, Klaus
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2009, 84 (03) : 159 - 170
  • [24] Treatment of Osteoporosis with Parathyroid Hormone and Teriparatide
    Johannes Pleiner-Duxneuner
    Elisabeth Zwettler
    Eleftherios Paschalis
    Paul Roschger
    Valerie Nell-Duxneuner
    Klaus Klaushofer
    [J]. Calcified Tissue International, 2009, 84 : 159 - 170
  • [25] Comparison of Efficacy of Teriparatide (Parathyroid Hormone 1-34) Alone and in Combination with Zoledronic Acid for Osteoporosis in Postmenopausal Women
    Wei, Kang
    Qu, Yuxing
    Gao, Yi
    Ma, Yong
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2021, 31 (02): : 240 - 242
  • [26] Bisphosphonates affect signaling pathways utilized by teriparatide [rhPTH(1-34)].
    Sun, Q
    Katz, RW
    Morris, SA
    Bilezikian, JP
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S230 - S231
  • [27] Recombinant human PTH 1-34 (Forteo): An anabolic drug for osteoporosis
    Deal, C
    Gideon, J
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 2003, 70 (07) : 585 - +
  • [28] TERIPARATIDE (RHPTH [1-34]) TREATMENT IMPROVES THE STRUCTURE OF THE PROXIMAL FEMUR IN WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FRACTURE PREVENTION TRIAL
    Scmanick, L. M.
    Uusi-Rasi, K.
    Zanchetta, J. R.
    Bogado, C. E.
    Eriksen, E. F.
    Sato, M.
    Beck, T. J.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S37 - S37
  • [29] Position paper on the indications for the use of parathyroid hormone (PTH 1-34) in the treatment of osteoporosis
    Brown, S. L.
    [J]. JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2009, 14 (01) : 61 - 62
  • [30] Endogenous intact PTH is suppressed during teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis
    Anastasilakis, Athanasios D.
    Polyzos, Stergios A.
    Goulis, Dimitrios G.
    Slavakis, Aristides
    Efstathiadou, Zoe
    Kita, Marina
    Koukoulis, George
    Avramidis, Avraam
    [J]. ENDOCRINE JOURNAL, 2008, 55 (03) : 613 - 616
12345